We Operate with Uncompromising Quality & Compliance
We are a specialized validation and EU GMP consulting firm dedicated to helping pharmaceutical, biotechnology, and healthcare manufacturers achieve and maintain robust regulatory compliance. We provide independent, objective guidance and practical, risk‑based solutions across the full validation lifecycle, ensuring your facilities, processes, equipment, and systems consistently meet global regulatory expectations.
Fiduciary
A commitment to acting as an independent, trusted advisor focused on your long‑term compliance and product quality.
Integrated
End‑to‑end validation and EU GMP consulting, integrating process, equipment, utilities, computerized systems, and quality systems.
Highly Personalized
Tailored, site‑specific solutions built on your products, processes, and risk profile—not generic templates.
Experienced
A senior team of validation engineers and quality consultants with decades of hands‑on EU GMP, FDA, WHO, and PIC/S experience.
Here's How We Got Started
The Begining
Our story begins in 1990, when our founding team launched a dedicated validation and quality consulting practice to support local pharmaceutical manufacturers.
Acquisition
Finovate has been acquired by NM Holdings, LP, a financial services distribution company, to drive future growth and support ongoing mergers and acquisitions plans.
Partnership
Finovate has formed a partnership with Meks Capital Group, LLC, a financial services holding company, to drive continued growth through mergers and acquisitions.
Expansion
Finovate has been acquired by Move Holdings, LP, a financial services distribution company, to fuel future growth and advance ongoing mergers and acquisitions strategies.
We Engineer Compliance You Can Rely On
Guided by a clear focus on product quality and patient safety, we work side‑by‑side with your teams to design, execute, and maintain practical validation and quality system solutions. Rather than applying one‑size‑fits‑all checklists, we collaborate closely to understand your processes, risks, and regulatory obligations—then deliver end‑to‑end support that is efficient, defensible, and fully aligned with EU GMP expectations.
“Our purpose is to help regulated manufacturers build, validate, and sustain processes that reliably deliver safe, effective, and high‑quality products to patients everywhere.”
John Smith
2024 Diversity, Equity, and Inclusion Report
- 2025
